Aradigm provides "conceptualization-to-clinic to market" needle-free drug delivery solutions designed to enhance the market competitiveness of existing and developmental-stage pharmaceutical
Founded in 1991, Aradigm is an innovator in the development of pulmonary drug products that enable patients to comfortably self-administer drugs without the use of needles. Through its proprietary AERx® platform and novel drug formulations, Aradigm is developing respiratory care products that utilize the surface areas of the lung to deliver a wide range of therapeutics.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Aradigm
3929 Point Eden Way
Hayward
California
94545 California
All rights reserved. Terms and Conditions | Contact us
